Tegaserod

替加色罗

Report date: 2025/08/19 16:28:03
NME

Base Information

Drug NameTegaserod
Drug Alias Name德加色得Tegaserod Maleate马来酸替加色罗Tegaserodum马来酸替加罗德 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsDiabetic GastroparesisHeartburnDyspepsia +[7] 
Global Approved IndicationsConstipationIrritable Bowel Syndrome
Approved Indications in ChinaIrritable Bowel Syndrome
Original Approved Country/TerritoryUnited States
Original Approved Date2002/07/24
Country/TerritoryUnited StatesSingaporeTaiwan +[9] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaWithdrawn
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma AgAlfasigma Usa IncNovartis Europharm Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsDiabetic GastroparesisHeartburnDyspepsia +[7] 

Other Information

ATC CodeA06AX06
Related LinksWikipediaDrugBankKEGG